keyword
MENU ▼
Read by QxMD icon Read
search

NEJM hematology

keyword
https://www.readbyqxmd.com/read/23233598/point-counterpoint-early-stage-hodgkin-lymphoma-and-the-role-of-radiation-therapy
#1
REVIEW
Ralph M Meyer, Richard T Hoppe
The results of recent clinical trials for the management of limited-stage Hodgkin lymphoma have led to considerable debate, especially regarding the role of radiation therapy. This review highlights those recent trials and provides perspectives regarding their interpretation from a radiation oncologist and a hematologist. The trial protocol is available at http://www.nejm.org/doi/suppl/10.1056/NEJMoa1111961/suppl_file/nejmoa1111961_protocol.pdf.
2012: Hematology—the Education Program of the American Society of Hematology
https://www.readbyqxmd.com/read/22526868/infectious-diseases-publications-in-leading-medical-journals-a-comparative-analysis
#2
COMPARATIVE STUDY
G Fätkenheuer, F Roer, B Hirschel, O A Cornely, B Salzberger
The representation of medical disciplines in leading journals may provide valuable information on their respective importance for both researchers and funding agencies. We were interested in the scientific contribution of infectious diseases to leading medical journals and their ranking compared to other medical disciplines. Original articles and short communications in three leading medical journals from 2003 to 2009 were analyzed by contributing medical discipline and by nation: The New England Journal of Medicine (NEJM), The Lancet, and the Journal of the American Medical Association (JAMA)...
October 2012: European Journal of Clinical Microbiology & Infectious Diseases
https://www.readbyqxmd.com/read/20410466/adequacy-of-published-oncology-randomized-controlled-trials-to-provide-therapeutic-details-needed-for-clinical-application
#3
Jennifer M Duff, Helen Leather, Edmund O Walden, Kourtney D LaPlant, Thomas J George
BACKGROUND: Randomized controlled trials (RCTs) improve clinical care through evidence-based results. Guidelines exist for RCT result reporting, but specific details of therapeutic administration promote clinical application and reproduction of the trial design. We assess the reporting methodology in RCTs published in major oncology journals. METHODS: Ten essential elements of RCT reporting were identified and included drug name, dose, route, cycle length, maximum number of cycles, premedication, growth factor support, patient monitoring parameters, and dosing adjustments for hematologic and organ-specific toxicity...
May 19, 2010: Journal of the National Cancer Institute
https://www.readbyqxmd.com/read/16120409/the-neurological-presentations-of-childhood-and-adult-mitochondrial-disease-established-syndromes-and-phenotypic-variations
#4
Andrea L Gropman
Mitochondrial disorders are caused by mutations of nuclear or mitochondrial DNA encoded genes involved in oxidative phosphorylation (OXPHOS). Mutations in these critical genes are associated with specific clinical syndromes with diverse presentations (DiMauro and Schon, 2003. NEJM 348, 2656; Hart et al., 2002. Mitochondrial Disorders in Neurology). Since mitochondria are present in many of our organs and play a key role in energy metabolism, mitochondrial encephalomyopathies often present as multisystem disorders which may manifest with neurologic, cardiac, endocrine, gastrointestinal, hepatic, renal and/or hematologic involvement (DiMauro and Bonilla, 1997...
September 2004: Mitochondrion
https://www.readbyqxmd.com/read/10945001/-pilot-study-of-dose-intensive-weekly-chemotherapy-followed-by-cisplatin-plus-etoposide-with-concurrent-thoracic-irradiation-for-limited-disease-small-cell-lung-cancer-west-japan-thoracic-oncology-group
#5
MULTICENTER STUDY
T Isobe, M Fukuoka, S Negoro, T Sugiura, M Kawahara, S Kudoh, J Araki, K Nakagawa, M Yokozaki, M Yamakido, Y Ariyoshi
It was reported from a previous randomized trial (NEJM 329: 1848, 1993) that a moderate increase in the initial dose of cyclophosphamide and cisplatin improves the survival of patients with LDSCLC. Rapid administration of several active agents over a short treatment period, such as the CODE regimen, is a potentially usefully strategy for increasing the initial dose intensity. Based on these findings, we conducted a pilot study of CODE (C: 25 mg/m2, day 1, weeks 1-4, O: 1 mg/m2, day 1, weeks 2, 4, D: 40 mg/m2, day 1, weeks 1, 3, E: 80 mg/m2, days 1-3, weeks 1, 3) chemotherapy for the first 4 weeks followed by PE therapy (P: 80 mg/m2, day 1, E: 100 mg/m2, days 1-3, for 3 cycles) with concurrent TRT (1...
July 2000: Gan to Kagaku Ryoho. Cancer & Chemotherapy
https://www.readbyqxmd.com/read/8882964/treatment-of-three-patients-with-systemic-mastocytosis-with-interferon-alpha-2b
#6
A S Worobec, A S Kirshenbaum, L B Schwartz, D D Metcalfe
It has been reported that the administration of interferon alpha-2b is of potential benefit in the treatment of mastocytosis based on a single patient study (NEJM, Feb 27, 1992, 326(9):619-623). Following this report, we administered interferon alpha-2b at a dose of 4 to 5 million units per square meter of body surface area for at least 12 months to one patient with mastocytosis with an associated hematologic disorder (patient 1), one patient with aggressive systemic mastocytosis (patient 2), and one patient with indolent mastocytosis (patient 3)...
August 1996: Leukemia & Lymphoma
https://www.readbyqxmd.com/read/8833777/risk-of-low-red-or-white-blood-cell-count-related-to-estimated-benzene-exposure-in-a-rubberworker-cohort-1940-1975
#7
COMPARATIVE STUDY
E Ward, R Hornung, J Morris, R Rinsky, D Wild, W Halperin, W Guthrie
This study evaluated the relationship between benzene exposure and low white blood cell (WBC) and red blood cell (RBC) counts. Hematologic screening data collected over a 35 year period at a rubber hydrochloride manufacturing plant were analyzed; an increased risk of leukemia had been demonstrated previously among workers at the plant [Infante et al. (1977).' Lancet 2:76-78; Rinsky et al. (1981): Am J Ind Med 2:217-45 (1987): NEJM 316:1044-1050/. Hematologic screening data were available for 657 of 1,037 (63...
March 1996: American Journal of Industrial Medicine
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"